Elevated FOXG1 supports exit from quiescence in neural stem cells through FoxO6

Abstract

SummaryThe molecular mechanisms controlling the balance of quiescence and proliferation in adult neural stem cells (NSCs) are often deregulated in brain cancers such as glioblastoma (GBM). Previously, we reported that FOXG1, a forebrain-restricted neurodevelopmental transcription factor, is frequently upregulated in glioblastoma stem cells (GSCs) and limits the effects of cytostatic pathways, in part by repression of the tumour suppressor Foxo3. Here, we show that increased FOXG1 upregulates FoxO6, a more recently discovered FoxO family member with potential oncogenic functions. Although genetic ablation of FoxO6 in proliferating NSCs has no effect on the cell cycle or entry into quiescence, we find that FoxO6-null NSCs can no longer efficiently exit quiescence following FOXG1 elevation. Increased FoxO6 results in the formation of large acidic vacuoles, reminiscent of Pak1-regulated macropinocytosis. Consistently, Pak1 expression is upregulated by FOXG1 overexpression and downregulated upon FoxO6 loss in proliferative NSCs. These data suggest a pro-oncogenic role for FoxO6 in controlling the exit from quiescence in NSCs, and shed light on the functions of this underexplored FoxO family member.Research highlightsFoxO6 is a downstream effector of elevated FOXG1 in mouse NSCs and GSCs.Upregulation of FoxO6 is necessary for FOXG1 to drive efficient quiescence exit of NSCs.FoxO6 overexpression stimulates macropinocytosis, a process regulated by the actin cytoskeleton regulator Pak1.Pak1 is upregulated by FOXG1 overexpression and downregulated upon FoxO6 loss.